ArticleThe Journal of biological chemistry2026
G protein regulatory network shapes magnitude and kinetics of behavioral responses in an engineered opioid receptor model.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
G protein-coupled receptors (GPCRs) control essential neuronal functions. One GPCR with prominent effects on the nervous system and animal behavior is the mu-opioid receptor (MOR). GPCRs mediate their effects by engaging a gamut of G proteins, which are inhibited by Regulators of G protein signaling (RGS). At present, how different RGS proteins regulate the magnitude and temporal kinetics of G protein signaling to affect behavior remains unclear. Here, we use an engineered cross-species Caenorhabditis elegans model of MOR signaling (tgMOR) to test how multiple RGS proteins shape MOR signaling and behavioral responses to opioids. Our results indicate opioid-induced effects on locomotor behavior in tgMOR are primarily mediated by Gαo and are modified by opposing Gαq action. We further delineate that EGL-10 (RGS7) is a primary RGS that modulates the magnitude of MOR-meditated responses. In a differential effect, EAT-16 (RGS9) and its regulator RSBP-1 (R7BP) principally influence the timing of behavioral response onset. Thus, a multi-layered RGS network is required to shape the magnitude and kinetics of MOR signaling and ensuing behavioral responses to opioids. The G protein regulatory network revealed here might also have broader implications for other Gαo/i-coupled receptors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.